Eris delivers 11% yoy growth in Domestic Formulations with 37% EBIDTA margin in FY26..
Dailymirror.news,Ahmedabad, May 21st, 2026: Eris Lifesciences Limited (“Eris Lifesciences” or the “Company”) (BSE: 540596; NSE: ERIS), a leading Indian branded formulations manufacturing company,

